Endocrine tumors

Disease ID:296
Name:Endocrine tumors
Associated with:1 targets
0 immuno-relevant targets
0 immuno-relevant ligands


SST2 receptor
Role:  Indium-111-pentetreotide scintigraphy and somatostatin receptor expression are new prognosis factors for malignant well-differentiated endocrine tumours.
References:  1


No ligand related data available for Endocrine tumors


Show »

1. Asnacios A, Courbon F, Rochaix P, Bauvin E, Cances-Lauwers V, Susini C, Schulz S, Boneu A, Guimbaud R, Buscail L. (2008) Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. J. Clin. Oncol., 26 (6): 963-70. [PMID:18281671]